아토피피부염의 표현형과 내재형

키워드

참고문헌 (70)

1. Kim J, "Pathophysiology of atopic dermatitis : clinical implications", Allergy Asthma Proc, 40, pp.84~92 (2019)
2. Whiteley J, "The burden of atopic dermatitis in US adults : results from the 2013 National Health and Wellness Survey", Curr Med Res Opin, 32, pp.1645~1651 (2016)
3. 김병의, "Significance of Skin Barrier Dysfunction in Atopic Dermatitis", Allergy, Asthma & Immunology Research, 10(3), pp.207~215 (2018), 대한천식알레르기학회
4. Danso MO, "TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents", J Invest Dermatol, 134, pp.1941~1950 (2014)
5. Janssens M, "Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients", J Lipid Res, 53, pp.2755~2766 (2012)
6. 양현종, "소아 천식의 표현형과 내재형", Allergy Asthma & Respiratory Disease, 2(2), pp.85~90 (2014), 대한 소아알레르기 호흡기학회
7. Bieber T, "Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?", J Allergy Clin Immunol, 139(4S), pp.S58~S64 (2017)
8. Garmhausen D, "Characterization of different courses of atopic dermatitis in adolescent and adult patients", Allergy, 68, pp.498~506 (2013)
9. Lyons JJ, "Atopic dermatitis in children : clinical features, pathophysiology, and treatment", Immunol Allergy Clin North Am, 35, pp.161~183 (2015)
10. Williams HC, "The natural history of childhood eczema : observations from the British 1958 birth cohort study", Br J Dermatol, 139, pp.834~839 (1998)
11. Roduit C, "Phenotypes of atopic dermatitis depending on the timing of onset and progression in childhood", JAMA Pediatr, 171, pp.655~662 (2017)
12. Tanei R, "Clinical analyses of atopic dermatitis in the aged", J Dermatol, 35, pp.562~569 (2008)
13. Tanei R, "Atopic dermatitis in older adults : a viewpoint from geriatric dermatology", Geriatr Gerontol Int, 16(Suppl 1), pp.75~86 (2016)
14. Nygaard U, "TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis", J Eur Acad Dermatol Venereol, 30, pp.1930~1938 (2016)
15. Esaki H, "Early-onset pediatric atopic dermatitis is T(H)2 but also T(H)17 polarized in skin", J Allergy Clin Immunol, 138, pp.1639~1651 (2016)
16. Lee E, "Atopic dermatitis phenotype with early onset and high serum IL-13 is linked to the new development of bronchial hyperresponsiveness in school children", Allergy, 71, pp.692~700 (2016)
17. Tokura Y, "Extrinsic and intrinsic types of atopic dermatitis", J Dermatol Sci, 58, pp.1~7 (2010)
18. Suk-JinChoi, "Comparison of Transepidermal Water Loss, Capacitance and pH Values in the Skin between Intrinsic and Extrinsic Atopic Dermatitis Patients", Journal of Korean Medical Science, 18(1), pp.93~96 (2003), 대한의학회
19. Weidinger S, "Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations", J Allergy Clin Immunol, 118, pp.214~219 (2006)
20. Mori T, "Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis", Br J Dermatol, 162, pp.83~90 (2010)
21. Suárez-Fariñas M, "Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis", J Allergy Clin Immunol, 132, pp.361~370 (2013)
22. Guttman-Yassky E, "Low expression of the IL-23", Th17 pathway in atopic dermatitis compared to psoriasis, 2008, pp.181, 7420~7427
23. Howell MD, "Cathelicidin deficiency predisposes to eczema herpeticum", J Allergy Clin Immunol, 117, pp.836~841 (2006)
24. Illi S, "The natural course of atopic dermatitis from birth to age 7 years and the association with asthma", J Allergy Clin Immunol, 113, pp.925~931 (2004)
25. Silverberg JI, "Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization", Pediatr Allergy Immunol, 24, pp.476~486 (2013)
26. Thijs JL, "A panel of biomarkers for disease severity in atopic dermatitis", Clin Exp Allergy, 45, pp.698~701 (2015)
27. Thijs J, "Biomarkers for atopic dermatitis : a systematic review and meta-analysis", Curr Opin Allergy Clin Immunol, 15, pp.453~460 (2015)
28. Takayama G, "Periostin : a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals", J Allergy Clin Immunol, 118, pp.98~104 (2006)
29. Leung DY, "Atopic dermatitis: age and race do matter!", J Allergy Clin Immunol, 136, pp.1265~1267 (2015)
30. Heimall J, "Filaggrin mutations and atopy : consequences for future therapeutics", Expert Rev Clin Immunol, 8, pp.189~197 (2012)
31. Cascella R, "Full sequencing of the FLG gene in Italian patients with atopic eczema : evidence of new mutations, but lack of an association", J Invest Dermatol, 131, pp.982~984 (2011)
32. Li K, "FLG mutations in the East Asian atopic dermatitis patients : genetic and clinical implication", Exp Dermatol, 25, pp.816~818 (2016)
33. Akiyama M, "FLG mutations in ichthyosis vulgaris and atopic eczema : spectrum of mutations and population genetics", Br J Dermatol, 162, pp.472~477 (2010)
34. Noda S, "The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization", J Allergy Clin Immunol, 136, pp.1254~1264 (2015)
35. Damsker JM, "Th1 and Th17 cells : adversaries and collaborators", Ann N Y Acad Sci, 1183, pp.211~221 (2010)
36. Byung Eui Kim, "Epidermal Barrier in Atopic Dermatitis", Allergy, Asthma & Immunology Research, 4(1), pp.12~16 (2012), 대한천식알레르기학회
37. Irvine AD, "Filaggrin mutations associated with skin and allergic diseases", N Engl J Med, 365, pp.1315~1327 (2011)
38. Elias PM, "Basis for the barrier abnormality in atopic dermatitis : outside-inside-outside pathogenic mechanisms", J Allergy Clin Immunol, 121, pp.1337~1343 (2008)
39. Howell MD, "Cytokine modulation of atopic dermatitis filaggrin skin expression", J Allergy Clin Immunol, 120, pp.150~155 (2007)
40. Gutowska-Owsiak D, "IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion", Exp Dermatol, 21, pp.104~110 (2012)
41. Rodríguez E, "Meta-analysis of filaggrin polymorphisms in eczema and asthma : robust risk factors in atopic disease", J Allergy Clin Immunol, 123, pp.1361~1370.e7 (2009)
42. Wan J, "Influence of FLG mutations and TSLP polymorphisms on atopic dermatitis onset age", Ann Allergy Asthma Immunol, 118, pp.737~738.e1 (2017)
43. O’Regan GM, "Filaggrin in atopic dermatitis", J Allergy Clin Immunol, 122, pp.689~693 (2008)
44. De Benedetto A, "Tight junction defects in patients with atopic dermatitis", J Allergy Clin Immunol, 127, pp.773~786.e1-e7 (2011)
45. Hata TR, "History of eczema herpeticum is associated with the inability to induce human β-defensin(HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis", Br J Dermatol, 163, pp.659~661 (2010)
46. Ong PY, "Endogenous antimicrobial peptides and skin infections in atopic dermatitis", N Engl J Med, 347, pp.1151~1160 (2002)
47. Hara J, "High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis", J Invest Dermatol, 115, pp.406~413 (2000)
48. Li S, "Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis", Br J Dermatol, 177, pp.e125~e127 (2017)
49. Berdyshev E, "Lipid abnormalities in atopic skin are driven by type 2 cytokines", JCI Insight, 22(3), pp.e98006~
50. Simpson EL, "Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention", J Allergy Clin Immunol, 134, pp.818~823 (2014)
51. Czarnowicki T, "Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen(CLA)(+)TH2", TH1 cell imbalance, whereas adults acquire CLA(+)TH22, J Allergy Clin Immunol, pp.2015, 136[DOI]
52. Boguniewicz M, "Biologic therapy for atopic dermatitis : moving beyond the practice parameter and guidelines", J Allergy Clin Immunol Pract, 5, pp.1477~1487 (2017)
53. Egawa G, "Barrier dysfunction in the skin allergy", Allergol Int, 67, pp.3~11 (2018)
54. Howell MD, "Cytokine modulation of atopic dermatitis filaggrin skin expression", J Allergy Clin Immunol, 124(3 Suppl 2), pp.R7~R12 (2009)
55. Cornelissen C, "IL-31 regulates differentiation and filaggrin expression in human organotypic skin models", J Allergy Clin Immunol, 129, pp.426~433 (2012)
56. Koga C, "Possible pathogenic role of Th17 cells for atopic dermatitis", J Invest Dermatol, 128, pp.2625~2630 (2008)
57. Tan Q, "P38", ERK MAPK signaling pathways are involved in the regulation of filaggrin and involucrin by IL‑17, 2017, pp.16, 8863~8867
58. Eyerich S, "Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling", J Clin Invest, 119, pp.3573~3585 (2009)
59. Nograles KE, "IL-22-producing"T22"T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells", J Allergy Clin Immunol, 123, pp.1244~1252.e2 (2009)
60. Hamilton JD, "Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis", J Allergy Clin Immunol, 134, pp.1293~1300 (2014)
61. Snast I, "Are biologics efficacious in atopic dermatitis? A systematic review and meta-analysis", Am J Clin Dermatol, 19, pp.145~165 (2018)
62. Khattri S, "Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis", Exp Dermatol, 26, pp.28~35 (2017)
63. Saeki H, "Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis : a randomized, double-blind, placebo-controlled, phase II study", Br J Dermatol, 177, pp.419~427 (2017)
64. Ong PY, "Immune dysregulation in atopic dermatitis", Curr Allergy Asthma Rep, 6, pp.384~389 (2006)
65. Schlievert PM, "Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis", J Allergy Clin Immunol, 125, pp.39~49 (2010)
66. Simpson EL, "Patients with atopic dermatitis colonized with Staphylococcus aureus have a distinct phenotype and endotype", J Invest Dermatol, 138, pp.2224~2233 (2018)
67. Wollenberg A, "Viral infections in atopic dermatitis : pathogenic aspects and clinical management", J Allergy Clin Immunol, 112, pp.667~674 (2003)
68. Beck LA, "Phenotype of atopic dermatitis subjects with a history of eczema herpeticum", J Allergy Clin Immunol, 124, pp.260~269 (2009)
69. Sugita T, "Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects", J Clin Microbiol, 39, pp.3486~3490 (2001)
70. Takahata Y, "Cutaneous Malassezia flora in atopic dermatitis differs between adults and children", Br J Dermatol, 157, pp.1178~1182 (2007)

관련 논문AI추천